HIGHLIGHTS
- who: Henglong Hu and collaborators from the Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No, Jiefang Wuhan, China have published the research: Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects, in the Journal: (JOURNAL)
- what: A variety of OVs has shown promising benefits in the field of BC therapy that are primarily attributed to their ability to induce oncolysis and immunomodulation.
- how: 7 of 19 Based on these findings a phase I/II trial (CANON NCT02316171) was conducted to investigate the therapeutic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.